Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab + Chlorambucil Induction and Maintenance in Elderly CLL
NCT00738374Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2008
- Primary completion
- Jan 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in chronic lymphocytic leukemia (CLL), sponsored by Roche. Started Nov 2008; status: completed.
02
Drugs
rituximab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00738374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00738374.